Completed
Diagnostic Evaluation of Patients With Suspected Abnormalities of Gastric Secretion
What is being collected
Data Collection
Who is being recruted
Acid-Base Imbalance+24
+ Adenocarcinoma
+ Carcinoma
How is the trial designed
Observational
Study Start: January 1989
Summary
Principal SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated: March 5, 2008
Sourced from a government-validated database.Claim as a partner
Study start date: January 1, 1989
Actual date on which the first participant was enrolled.This study is an omnibus protocol used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities of gastric acid secretion. Gastric acid secretion is measured by means of analysis of gastric juices obtained by nasogastric suction. Other clinically indicated diagnostic procedures are performed depending on the patient's clinical state in order to reach a diagnosis.
Principal SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Last updated: March 5, 2008
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Acid-Base ImbalanceAdenocarcinomaCarcinomaDigestive System DiseasesDigestive System NeoplasmsDuodenal DiseasesEndocrine System DiseasesEndocrine Gland NeoplasmsGastrointestinal DiseasesGastrointestinal NeoplasmsIntestinal DiseasesMetabolic DiseasesNeoplasmsNeoplasms by Histologic TypeNeoplasms by SiteNeoplasms, Glandular and EpithelialParaneoplastic Endocrine SyndromesNutritional and Metabolic DiseasesPancreatic DiseasesPancreatic NeoplasmsParaneoplastic SyndromesPeptic UlcerStomach DiseasesCarcinoma, Islet CellAchlorhydriaZollinger-Ellison SyndromeGastrinoma
Criteria
Eligibility criteria not identified in the protocol.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Bethesda, United StatesOpen National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in Google MapsCompletedOne Study Center